CLINICAL_TRIALS
trial_result
· 2024-05-30
Clinical Trial Update: Hepatocyte Growth Factor to Improve Functioning in PAD [Phase 2]
Summary
Phase 2 trial of hepatocyte growth factor to improve functioning in peripheral artery disease has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Peripheral Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-05-30